中国临床医学
中國臨床醫學
중국림상의학
CLINICAL MEDICAL JOURNAL OF CHINA
2014年
5期
520-522,525
,共4页
银杏叶%急性脑梗死%疗效
銀杏葉%急性腦梗死%療效
은행협%급성뇌경사%료효
Gingko biloba%Acute cerebral infarction%Treatment effect
目的:分析银杏叶提取物治疗急性脑梗死的疗效及机制。方法:将44例急性脑梗死患者随机分为对照组(n=21)和试验组(n=23)。对照组应用阿司匹林及胞二磷胆碱进行治疗,试验组在对照组用药基础上加用银杏叶提取物口服治疗。在发病当天及治疗7 d、14 d 时,对两组患者进行神经功能缺损评分(采用改良爱丁堡—斯堪的那维亚评分,MESSS 评分)、日常生活能力评定(Barthel 指数),评价临床疗效。比较两组患者在发病当天及治疗7 d 时的血清超敏 C 反应蛋白(hs-CRP)、超氧化物歧化酶(SOD)、丙二醛(MDA)、内皮素-1(ET-1)、血栓素 B2(TXB2)水平的变化。结果:试验组与对照组治疗前后的 MESSS评分、Barthel 指数、血清 hs-CRP 水平差异无统计学意义(P >0.05);但试验组临床疗效优于对照组,血清 SOD、MDA、ET-1、TXB2水平改善较对照组明显(P <0.05)。结论:银杏叶提取物联合阿司匹林及胞二磷胆碱治疗急性脑梗死的疗效较好,且无不良反应;这可能是药物提高了患者血清 SOD 及降低了 MDA、ET-1、TXB2水平的缘故。
目的:分析銀杏葉提取物治療急性腦梗死的療效及機製。方法:將44例急性腦梗死患者隨機分為對照組(n=21)和試驗組(n=23)。對照組應用阿司匹林及胞二燐膽堿進行治療,試驗組在對照組用藥基礎上加用銀杏葉提取物口服治療。在髮病噹天及治療7 d、14 d 時,對兩組患者進行神經功能缺損評分(採用改良愛丁堡—斯堪的那維亞評分,MESSS 評分)、日常生活能力評定(Barthel 指數),評價臨床療效。比較兩組患者在髮病噹天及治療7 d 時的血清超敏 C 反應蛋白(hs-CRP)、超氧化物歧化酶(SOD)、丙二醛(MDA)、內皮素-1(ET-1)、血栓素 B2(TXB2)水平的變化。結果:試驗組與對照組治療前後的 MESSS評分、Barthel 指數、血清 hs-CRP 水平差異無統計學意義(P >0.05);但試驗組臨床療效優于對照組,血清 SOD、MDA、ET-1、TXB2水平改善較對照組明顯(P <0.05)。結論:銀杏葉提取物聯閤阿司匹林及胞二燐膽堿治療急性腦梗死的療效較好,且無不良反應;這可能是藥物提高瞭患者血清 SOD 及降低瞭 MDA、ET-1、TXB2水平的緣故。
목적:분석은행협제취물치료급성뇌경사적료효급궤제。방법:장44례급성뇌경사환자수궤분위대조조(n=21)화시험조(n=23)。대조조응용아사필림급포이린담감진행치료,시험조재대조조용약기출상가용은행협제취물구복치료。재발병당천급치료7 d、14 d 시,대량조환자진행신경공능결손평분(채용개량애정보—사감적나유아평분,MESSS 평분)、일상생활능력평정(Barthel 지수),평개림상료효。비교량조환자재발병당천급치료7 d 시적혈청초민 C 반응단백(hs-CRP)、초양화물기화매(SOD)、병이철(MDA)、내피소-1(ET-1)、혈전소 B2(TXB2)수평적변화。결과:시험조여대조조치료전후적 MESSS평분、Barthel 지수、혈청 hs-CRP 수평차이무통계학의의(P >0.05);단시험조림상료효우우대조조,혈청 SOD、MDA、ET-1、TXB2수평개선교대조조명현(P <0.05)。결론:은행협제취물연합아사필림급포이린담감치료급성뇌경사적료효교호,차무불량반응;저가능시약물제고료환자혈청 SOD 급강저료 MDA、ET-1、TXB2수평적연고。
Objective:To analyse the effect and machanism of gingko biloba extract in the treatment of acute cerebral infarc-tion.Methods:Forty-four patients diagnosed as acute cerebral infarction were randomly divided into the control group (n=21) and the test group (n=23).Patients in the control group took aspirin,cytidine diphosphate choline and other conventional med-icines,while the patients in the test group received gingko biloba extract capsules combined with the medicine which used in the control group.The parameters measured during the study were MESSS score,Barthel Index,outcomes,and high-sensitivity C-reaction protein(hs-CRP),superoxide dismutase(SOD),malondialdehyde(MDA),endothelin-1(ET-1),thromboxane B2(TXB2) levels.Results:Compared with the control group,the MESSS score,Barthel Index and hs-CRP level in the test group were not improved(P >0.05),but the total clinical effects and the SOD,MDA,ET-1,TXB2 levels were obviously improved(P <0.05). Conclusions:Via increasing the SOD levels and decreasing the MDA,ET-1,TXB2 levels,the treatment of gingko biloba extract combined with aspirin and cytidine diphosphate choline in acute cerebral infarction is effective and safe.